Many patients with dyslipidaemia remain at high cardiovascular risk despite using statins and other lipid-lowering therapies. Several new LDL-cholesterol-lowering strategies are, therefore, being ...
NAARDEN, The Netherlands--(BUSINESS WIRE)--Dezima Pharma (‘Dezima’), the biotechnology company developing innovative drugs in the field of dyslipidemia, today announced the publication of the phase 2b ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results